(Q36873947)

16 August 2017

Quetiapine at high doses for the treatment of refractory schizophrenia (English)

1 reference

16 August 2017

1 reference

7

Robert R Conley

1 reference

16 August 2017

Douglas L Boggs

1

1 reference

16 August 2017

Deanna L Kelly

2

1 reference

16 August 2017

Stephanie Feldman

3

1 reference

16 August 2017

Robert P McMahon

4

1 reference

16 August 2017

Matthew W Nelson

5

1 reference

16 August 2017

Yang Yu

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

20 February 2008

1 reference

16 August 2017

Schizophrenia Research

1 reference

16 August 2017

101

1 reference

16 August 2017

1-3

1 reference

16 August 2017

347-348

1 reference

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

Effect of antipsychotic withdrawal on extrapyramidal symptoms: statistical methods for analyzing single-sample repeated-measures data.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

High-dose quetiapine in treatment refractory schizophrenia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535767

10.1016/J.SCHRES.2008.01.013

4 September 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18281197

1 reference